-
Eli Lilly's patent problem
In 2009, Eli Lilly CEO John Lechleiter introduced a new drug development strategy called the Development Center of Excellence. The center's mission is...
-
BlackBerry's corporate problem
BlackBerry's rise was tied to its ability to play well with big companies. Will that also cause its fall?Since missing on its fiscal fourth quarter ea...
-
Apple’s curious PR problem
By Philip Elmer-DeWittThe tech press is buzzing this week with the news that a senior Apple (AAPL) vice president took the time to e-mail a blogger.Th...
-
Microsoft’s $2 billion online problem
By Adam LashinskyEven with Yahoo deal Microsoft will continue to struggle — and lose money — online.The anti-climatic deal of the year is now out. Lon...
-
The Problem with Palm's Pre
The handset rocks, but the wireless industry isn't so hot on adopting another mobile operating system.By Stephanie N. MehtaBy almost all measures the ...
-
Apple's little netbook problem
By Philip Elmer-DeWittPressure is mounting on Apple (AAPL) to do something about the netbook problem.IDC reported Friday that worldwide shipments of t...
-
Our dollar, China's $2 trillion problem
Could the United States and China be even more co-dependent than we thought?On Wednesday Fed chief Ben Bernanke became the first American official in ...
-
Harley-Davidson's aging biker problem
Harley-Davidson was the feel-good turnaround story of the 1990s and then the poster-boy for brand values in the 2000s. How often did you read that Har...
-
2010 Mini Cooper S Camden edition: Mission Control, we have a problem
Remember the talking cars of the 1970s, certain Japanese models that reminded you to fasten your seat-belts and so forth in an annoying automated voic...
-
大型藥企暢銷藥遭遇專利懸崖困境
分析公司Dickson Data及FiercePharma的信息顯示，大量產品專利即將失效。而幾家醫藥巨頭今年也即將面臨賬本底線的重大考驗。默克公司、諾華公司、百時美施貴寶公司以及禮來制藥的重要藥物均將面臨專利懸崖問題。默克公司遭受的影響最大：在每年為其創收達5億美元的藥物中，不低于四分之一的藥物專...
時間：
作者：
關鍵詞：
